Nomir Medical Technologies is categorized under Research and Development Laboratories in Waltham, MA and active since 2008.
Nomir Medical Technologies was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Richard Burtt at the company’s single location by writing to 307 Waverley Oaks Road # 109, Waltham, Massachusetts MA 02452 or by phoning (781) 893-1000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nomir Medical Technologies |
| Contact Person: | Richard Burtt |
| Address: | 307 Waverley Oaks Road # 109, Waltham, Massachusetts 02452 |
| Phone Number: | (781) 893-1000 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Nomir Medical Technologies was started in 2008 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Richard Burtt for inquiries that concern Nomir Medical Technologies by calling the company number (781) 893-1000, as your correspondence is most welcome. Additionally, the physical location of the single location of Nomir Medical Technologies can be found at the coordinates as well as the street address 307 Waverley Oaks Road # 109 in Waltham, Massachusetts 02452.
For its online presence, you may visit Nomir Medical Technologies’s website at and engage with its social media outlets through on Twitter and on Facebook.